The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, yet its legacy within the broader industry now presents questions about future yields . Alternative versions are undercutting market share, causing concerns that investing in companies heavily reliant to Viagra's once-dominant standing could be a problem